Euglycemic diabetic ketoacidosis associated with a sodium-glucose co transporter 2 inhibitor use in a trauma patient: a case report

Abstract Background Sodium-glucose co-transporter 2 inhibitors (SGLT2i), like empagliflozin, are widely prescribed for managing type 2 diabetes mellitus. However, they carry a rare but serious risk: euglycemic diabetic ketoacidosis (EDKA). EDKA’s atypical presentation, characterized by metabolic aci...

Full description

Saved in:
Bibliographic Details
Main Authors: Ophélie Dirand, Julie Dupont, Emmanuel Weiss, Myriam Lamamri
Format: Article
Language:English
Published: BMC 2025-08-01
Series:International Journal of Emergency Medicine
Subjects:
Online Access:https://doi.org/10.1186/s12245-025-00963-8
Tags: Add Tag
No Tags, Be the first to tag this record!